COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 2679: Articles 26781-26790  | Next

Immunity after COVID-19: protection or sensitization ?
Danchin, A., TURINICI, G.
10.1101/2020.05.21.20108860 — Posted: 2020-05-23
Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens
Bravi, F., Flacco, M. E., Carradori, T., Volta, C. A., Cosenza, G., De Togni, A., Acuti Martellucci, C., Parruti, G., Mantovani, L., Manzoli, L.
10.1101/2020.05.21.20109082 — Posted: 2020-05-23
Development and clinical application of a rapid and sensitive loop-mediated isothermalamplification test for SARS-CoV-2 infection
Hu, X., Deng, Q., Li, J., Chen, J., Wang, Z., Fang, Z., Li, H., Zhao, Y., Yu, P., Li, W., Wang, X., Li, S., Zhang, L., Hou, T.
10.1101/2020.05.20.20108530 — Posted: 2020-05-23
Hospital admissions in inflammatory rheumatic diseases during the COVID-19 pandemic: incidence and role of disease modifying agents
Fernandez-Gutierrez, B., Leon, L., Madrid, A., Rodriguez-Rodriguez, L., Freites, D., Font, J., Mucientes, A., Colomer, J. I., Jover, J. A., Abasolo, L.
10.1101/2020.05.21.20108696 — Posted: 2020-05-23
Psychological Impact of COVID-19 on Pakistani University Students and How They Are Coping
Salman, M., Asif, N., Mustafa, Z. U., Khan, T. M., Shehzadi, N., Hussain, K., Tahir, H., Raza, M. H., Khan, M. T.
10.1101/2020.05.21.20108647 — Posted: 2020-05-23
Recombinant SARS-CoV-2 spike proteins for sero-surveillance and epitope mapping
Jegouic, S. M., Loureiro, S., Thom, M., Paliwal, D., Jones, I. M.
10.1101/2020.05.21.109298 — Posted: 2020-05-22
A previously uncharacterized gene in SARS-CoV-2 illuminates the functional dynamics and evolutionary origins of the COVID-19 pandemic
Nelson, C. W., Ardern, Z., Goldberg, T. L., Meng, C., Kuo, C.-H., Ludwig, C., Kolokotronis, S.-O., Wei, X.
10.1101/2020.05.21.109280 — Posted: 2020-05-22
Systemic Effects of Missense Mutations on SARS-CoV-2 Spike Glycoprotein Stability and Receptor Binding Affinity
Teng, S., Sobitian, A., Rhoades, R., Liu, D., Tang, Q.
10.1101/2020.05.21.109835 — Posted: 2020-05-22
SARS-CoV-2 mutations and where to find them: An in silico perspective of structural changes and antigenicity of the Spike protein
Lemes Goncalves, R., Leite, T. C. R., Dias, B. d. P., Caetano, C. C. d. S., Souza, A. C. G. d., Batista, U. d. S., Barbosa, C. C., Reyes-Sandoval, A., Leomil Coelho, L. F., Silva, B. d. M.
10.1101/2020.05.21.108563 — Posted: 2020-05-22
Pooling nasopharyngeal swab specimens to increase testing capacity for SARS-CoV-2
Anderson, C., Castillo, F., Koenig, M., Managbanag, J.
10.1101/2020.05.22.110932 — Posted: 2020-05-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).